Related Experiment Video

Updated: Mar 25, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

16.9K

Cortical gray matter loss in schizophrenia: Could microglia be the culprit?

Valentino Rački1, Daniela Petrić2, Natalia Kučić1

  • 1Department of Physiology and Immunology, Faculty of Medicine, University of Rijeka, Croatia.

Medical Hypotheses
|February 17, 2016
PubMed

Insights

Microglia may cause cortical gray matter loss in schizophrenia through abnormal pruning and reduced neurotrophic factors. Measuring serum biomarkers in early-onset patients could reveal microglial activation states and guide new therapeutic strategies.

Area of Science:

  • Neuroscience
  • Immunology
  • Psychiatry

Background:

  • Cortical gray matter loss in schizophrenia is irreversible and worsens with each psychotic episode.
  • Microglial cells, part of the innate immune system, play crucial roles in synaptic pruning, neuronal health, and synaptic plasticity.
  • Dysfunctional microglial activity is implicated in neurodegenerative processes.

Purpose of the Study:

  • To investigate the hypothesis that microglia contribute to cortical gray matter loss in schizophrenia.
  • To explore the role of abnormal synaptic pruning, phagocytosis of stressed neurons, and deficient neurotrophic factor release by microglia.
  • To propose a research methodology for validating these hypotheses in first-episode, early-onset schizophrenia patients.

Main Methods:

  • Propose measuring serum levels of specific biomarkers: milk fat globule-EGF factor 8 (MFG-E8), complement component 1q (C1q), brain-derived neurotrophic factor (BDNF), interleukin-6 (IL-6), and interleukin-10 (IL-10).
  • Analyze these biomarkers in serum samples from first-episode, early-onset schizophrenia patients.
  • Correlate biomarker levels with disease stages to understand microglial activation states.

Main Results:

  • This section is based on a proposed study and does not contain results yet.
  • The study aims to provide insights into microglial activation patterns in schizophrenia.
  • Expected outcomes include identifying specific microglial signatures associated with disease progression.

Conclusions:

  • If the hypothesis is supported, it suggests microglia are key drivers of gray matter loss in schizophrenia.
  • This research could pave the way for developing targeted therapies to mitigate neurodegeneration.
  • Potential therapeutic interventions could aim to modulate microglial activity, potentially improving negative symptoms and cognitive deficits.

More Related Videos

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

11.2K
Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain10:40

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

35.6K

Related Concept Videos

Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
1.0K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.4K
Schizophrenia01:17

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
1.6K
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
829